The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality

TH Karlsen, N Sheron, S Zelber-Sagi, P Carrieri… - The Lancet, 2022 - thelancet.com
Executive summary Liver diseases have become a major health threat across Europe, and
the face of European hepatology is changing due to the cure of viral hepatitis C and the …

Defining paediatric metabolic (dysfunction)-associated fatty liver disease: an international expert consensus statement

M Eslam, N Alkhouri, P Vajro, U Baumann… - The Lancet …, 2021 - thelancet.com
The term non-alcoholic fatty liver disease (NAFLD), and its definition, have limitations for
both adults and children. The definition is most problematic for children, for whom alcohol …

Redefining fatty liver disease: an international patient perspective

G Shiha, M Korenjak, W Eskridge… - The lancet …, 2021 - thelancet.com
Despite its increased recognition as a major health threat, fatty liver disease associated with
metabolic dysfunction remains largely underdiagnosed and undertreated. An international …

Defining comprehensive models of care for NAFLD

JV Lazarus, QM Anstee, H Hagström, K Cusi… - Nature reviews …, 2021 - nature.com
Non-alcoholic fatty liver disease (NAFLD) is now the leading cause of chronic liver disease
globally. Despite the increased demand placed on health-care systems, little attention has …

Risks and clinical predictors of cirrhosis and hepatocellular carcinoma diagnoses in adults with diagnosed NAFLD: real-world study of 18 million patients in four …

M Alexander, AK Loomis, J Van Der Lei… - BMC medicine, 2019 - Springer
Background Non-alcoholic fatty liver disease (NAFLD) is a common condition that
progresses in some patients to steatohepatitis (NASH), cirrhosis and hepatocellular …

The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease

N Mendez-Sanchez, M Arrese, A Gadano… - The Lancet …, 2021 - thelancet.com
Summary The Latin American Association for the Study of the Liver (Asociación
Latinoamericana para el Estudio del Hígado; ALEH) represents liver professionals in Latin …

Early prediction of incident liver disease using conventional risk factors and gut-microbiome-augmented gradient boosting

Y Liu, G Meric, AS Havulinna, SM Teo, F Åberg… - Cell Metabolism, 2022 - cell.com
The gut microbiome has shown promise as a predictive biomarker for various diseases.
However, the potential of gut microbiota for prospective risk prediction of liver disease has …

Metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: the patient and physician perspective

W Eskridge, DR Cryer, JM Schattenberg… - Journal of Clinical …, 2023 - mdpi.com
Diagnosing and managing metabolic dysfunction-associated steatotic liver disease
(MASLD) remains a major challenge in primary care due to lack of agreement on diagnostic …

[HTML][HTML] Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of …

G Marchesini, E Bugianesi, P Burra, F Marra… - Digestive and Liver …, 2022 - Elsevier
Nonalcoholic fatty liver disease (NAFLD) is a common and emerging liver disease in adults,
paralleling the epidemic of obesity and diabetes, and leading to worrisome events …

The egyptian clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease

Y Fouad, G Esmat, R Elwakil, S Zakaria… - Saudi Journal of …, 2022 - journals.lww.com
The landscape of chronic liver disease in Egypt has drastically changed over the past few
decades. The prevalence of metabolic-associated fatty liver disease (MAFLD) has risen to …